Document is current
Any future updates will be listed below
-
Authors
Pauli, Jessica https://orcid.org/0000-0001-5984-3529
Garger, Daniel https://orcid.org/0000-0002-0544-3383
Peymani, Fatemeh
Wettich, Justus
Sachs, Nadja https://orcid.org/0000-0001-8031-017X
Wirth, Johannes https://orcid.org/0000-0002-2216-3332
Steiger, Katja https://orcid.org/0000-0002-7269-5433
Hillig, Christina https://orcid.org/0000-0001-7447-547X
Zhang, Hanrui https://orcid.org/0000-0001-8655-938X
Tabas, Ira
Tall, Alan https://orcid.org/0000-0002-7708-2417
Li, Mingyao https://orcid.org/0000-0001-8180-0621
Reilly, Muredach P. https://orcid.org/0000-0002-3035-9386
Branzan, Daniela
Prokisch, Holger
Menden, Michael P. https://orcid.org/0000-0003-0267-5792
Maegdefessel, Lars https://orcid.org/0000-0001-5228-2634
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P01HL172741-01)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 4 December 2025
First Online: 18 December 2025
Competing interests
: L.M. has received research funds from Novo Nordisk (Malov, Denmark), Roche Diagnostics (Rotkreuz, Switzerland), and Bitterroot Bio (Palo Alto, CA, USA), and serves as a scientific advisor to Novo Nordisk (Malov, Denmark), DrugFarm (Guilford, CT, USA), and Angiolutions (Hannover, Germany). M.P.M. is a former employee of AstraZeneca (Cambridge, UK). MPM collaborates and is financially supported by GlaxoSmithKline (London, UK), F. Hoffmann-La Roche (Basel, Switzerland), and AstraZeneca (Cambridge, UK). D.B. serves on the advisory board for Terumo Aortic (UK), Medtronic (Minneapolis, USA), and COOK Medical (Bloomington, USA) and has received research funds and speaking fees from Artivion (Kennesaw, USA), Becton, Dickinson and Company (New Jersey, USA), Getinge (Gothenburg, Sweden), and Endologix (Irvine, USA). None of the relationships conflict with the present work. The other authors declare no relevant competing interests.
